![Caroline Diaz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Caroline Diaz
General Counsel at DOVA PHARMACEUTICALS, INC.
Caroline Diaz active positions
Companies | Position | Start | End |
---|---|---|---|
DOVA PHARMACEUTICALS, INC. | General Counsel | - | - |
VERONA PHARMA PLC | General Counsel | 2021-09-30 | - |
Career history of Caroline Diaz
Former positions of Caroline Diaz
Companies | Position | Start | End |
---|---|---|---|
ReViral Ltd.
![]() ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | General Counsel | - | - |
Training of Caroline Diaz
Hope College | Undergraduate Degree |
University of North Carolina at Chapel Hill | Graduate Degree |
Statistics
International
United States | 4 |
United Kingdom | 3 |
Operational
General Counsel | 3 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VERONA PHARMA PLC | Health Technology |
Private companies | 2 |
---|---|
Dova Pharmaceuticals, Inc.
![]() Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
ReViral Ltd.
![]() ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Caroline Diaz
- Experience